The rejection follows the company’s previously dismissed proposal to install wind turbines at the facility.
The company, which has accepted the decision, is working with Marine Scotland to evaluate the bladeless tidal turbines feasibility, reports FiercePharmaManufacturing citing Montrose Review.
GSK aims to achieve its target using 5 MW from wind, 0.66 MW from tidal and 1.15 MW from a combined heat and power plant, according to the news agency.